Zantac Pulled from Market
April 2, 2020 – Philadelphia, PA
The US Food and Drug Administrations has called for Zantac to be pulled from the market immediately. According to the FDA, the over the counter acid reflux and heartburn drug may contain a probable human carcinogen. After an investigation it was found that levels of N-nitrosodimethylamine or NDMA in Zantac increase over time when stored at high temperatures.
The FDA is sending letters to manufacturers requesting they withdraw their products from the market. Consumers are also advised to stop taking any ranitidine tablets or liquid medications they currently have and dispose of them properly. The FDA recommends speaking with your doctor about other treatment options.
If you or someone you love developed health issues after taking Zantac you may be entitled to compensation. Our team of attorneys is committed to providing the legal representation you deserve for your injuries. Call or contact us online to get the legal help you need, today.